Lung Cancer Study
A phase 1B/2 study of Viagenpumatucel‑L (HS-110) in combination with multiple treatment regimens in patients with Non-Small Cell Lung Cancer (The “DURGA” Trial)
A phase 1B/2 study of Viagenpumatucel‑L (HS-110) in combination with multiple treatment regimens in patients with Non-Small Cell Lung Cancer (The “DURGA” Trial)